A. Melnyk - Concepedia

Author

A. Melnyk

Also Known As

A Melnyk, A. Melnyk, A.M. Melnyk, Antonii Melnyk

Publications

456

Citations

H-Index

Concepts

All Affiliations

A. Melnyk is an author at Sarah Cannon specializing in cancer therapeutics, radiation oncology, and oncology.

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	99
2	Engineering	1	1	58
3	Health Sciences	1	1	79
4	Natural Sciences	1	1	58
5	Applied Physics	1	1	58

A. Melnyk

Publications

432

Citations

H-Index

Page 1

	Year	Citations
Evaluation of the Revised European-American Lymphoma Classification Confirms the Clinical Relevance of Immunophenotype in 560 Cases of Aggressive Non-Hodgkin's Lymphoma A. Melnyk, William Pugh, F. Cabannillas Blood	1997	235
Updated survival and outcomes for older adults with inoperable stage III non-small-cell lung cancer treated with cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel: analysis of a phase III trial from the Hoosier Oncology Group (HOG) and US Oncology Shadia I. Jalal, Heather Riggs, A. Melnyk, Annals of Oncology Radiation MedicineHoosier Oncology GroupMedicineCancer ManagementPhase Iii Trial	2011	79
The PCPDTBT Family: Correlations between Chemical Structure, Polymorphism, and Device Performance Gisela L. Schulz, Florian S. U. Fischer, Daniel Trefz, Macromolecules EngineeringOrganic ElectronicsMolecular BiologyComputational ChemistryChemistry	2017	58
Three-hour paclitaxel infusion in patients with refractory and relapsed non-Hodgkin's lymphoma. Anas Younes, A H Sarris, A. Melnyk, Journal of Clinical Oncology	1995	40
Ridaforolimus (AP23573; MK-8669) in Combination with Trastuzumab for Patients with HER2-Positive Trastuzumab-Refractory Metastatic Breast Cancer: A Multicenter Phase 2 Clinical Trial. Denise A. Yardley, Milton Seiler, Isabelle Ray‐Coquard, Cancer Research Tumor BiologyBreast OncologyOncologyT ResistanceMulticenter Phase 2	2009	20

Page 1